# Can Semax enhance mitochondrial health in ischemic brain conditions?

Canonical source: https://retacompare.com/research/can-semax-enhance-mitochondrial-health-in-ischemic-brain-conditions

Peptide Longevity Q&A · 2021-03-04


    Research indicates that Semax may enhance mitochondrial health by modulating PGC-1α expression in ischemic brain conditions. In a rat model, Semax administration was associated with increased PGC-1α expression and preservation of neuron numbers, suggesting a neuroprotective effect.

 What the research shows

The study investigated the effects of Semax, an ACTH (4-7) analog, on ischemic stroke in a rat model induced by photochemical thrombosis. Semax was administered intranasally at a dosage of 25 µg/kg for seven days. The researchers measured the expression of PGC-1α, a crucial regulator of mitochondrial biogenesis, and its dependent protein markers related to mitochondriogenesis, angiogenesis, and synaptogenesis. These measurements were taken at various time points (Days 1, 3, 7, and 21) following the induction of thrombosis. The study found that PGC-1α expression was suppressed in the affected brain region from 24 hours to 21 days post-thrombosis. However, the administration of Semax was linked to the preservation of neuron numbers and the stimulation of PGC-1α nuclear translocation.

 Why it matters for longevity

The findings suggest that Semax may play a role in enhancing mitochondrial health, which is vital for longevity and overall brain function. Mitochondria are essential for energy production, and their dysfunction is associated with various age-related diseases, including neurodegenerative conditions. By promoting PGC-1α activity, Semax could help maintain mitochondrial integrity and function, potentially extending healthspan and mitigating age-related decline in cognitive abilities. This research highlights the potential of pharmacological agents like Semax in neuroprotective therapies aimed at improving brain health during aging.

 Key findings at a glance

Semax was tested in a rat model of ischemic stroke.

It was administered intranasally at a dose of 25 µg/kg for seven days.

Semax administration preserved neuron numbers in the ischemic region.

It stimulated the nuclear translocation of PGC-1α in neurons.

PGC-1α expression was suppressed following ischemic injury.

Semax may enhance mitochondrial health by modulating PGC-1α activity.

 How Semax works (background)

Semax is a synthetic peptide derived from the adrenocorticotropic hormone (ACTH) fragment. It is known for its neuroprotective properties, particularly in conditions of ischemia. The primary mechanism through which Semax exerts its effects is by modulating the expression of PGC-1α, a transcription coactivator that regulates genes involved in mitochondrial biogenesis and function. By enhancing PGC-1α activity, Semax can promote the production of new mitochondria, improve energy metabolism, and support neuronal survival in the face of ischemic injury.

 Safety, caveats, and what we don't yet know

While the study provides promising insights into the neuroprotective effects of Semax, it is important to note that this research was conducted in a preclinical model. The findings may not directly translate to human subjects, and further studies are necessary to establish the safety and efficacy of Semax in clinical settings. Additionally, the long-term effects of Semax on mitochondrial health and overall brain function in aging populations remain to be explored. There is also a need to investigate the optimal dosing and administration routes in humans.

 Bottom line

Semax may enhance mitochondrial health by modulating PGC-1α expression, which is crucial for neuronal survival in ischemic conditions. This suggests potential implications for neuroprotection and longevity.

 Related questions

 Does Semax promote neurogenesis in aging brains?

Research indicates that Semax may support neurogenesis by enhancing the expression of neurotrophic factors and promoting neuronal survival, although specific studies in aging models are limited.

 Can Semax improve cognitive function in older adults?

While preclinical studies suggest that Semax has neuroprotective effects, further clinical research is needed to determine its impact on cognitive function in older adults.

 What are the mechanisms of action for Semax?

Semax primarily works by modulating PGC-1α expression, promoting mitochondrial biogenesis, and enhancing neuroprotection, which could be beneficial in various neurological conditions.

 Source: PubMed · Brain Sci · published 2021-03-04.

## Sources

- PubMed · Brain Sci: https://pubmed.ncbi.nlm.nih.gov/33806692/